

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.55356540 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.55356540 |
| 3 | axon ensheathment (GO:0008366) | 5.66376595 |
| 4 | ensheathment of neurons (GO:0007272) | 5.66376595 |
| 5 | myelination (GO:0042552) | 5.61546617 |
| 6 | myelin maintenance (GO:0043217) | 5.11822947 |
| 7 | actin-myosin filament sliding (GO:0033275) | 5.09757071 |
| 8 | muscle filament sliding (GO:0030049) | 5.09757071 |
| 9 | skeletal muscle contraction (GO:0003009) | 4.84572407 |
| 10 | creatine metabolic process (GO:0006600) | 4.72775443 |
| 11 | L-amino acid import (GO:0043092) | 4.57322018 |
| 12 | fatty acid elongation (GO:0030497) | 4.37136021 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.31234730 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 4.31234730 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.31234730 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.31234730 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.31234730 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.31234730 |
| 19 | regulation of skeletal muscle contraction (GO:0014819) | 4.30594516 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.29382040 |
| 21 | regulation of relaxation of muscle (GO:1901077) | 4.14987809 |
| 22 | actin-mediated cell contraction (GO:0070252) | 4.05347235 |
| 23 | regulation of somitogenesis (GO:0014807) | 3.92238623 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.91517067 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 3.85753758 |
| 26 | oligodendrocyte differentiation (GO:0048709) | 3.77765895 |
| 27 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.76839742 |
| 28 | activated T cell proliferation (GO:0050798) | 3.73820166 |
| 29 | astrocyte development (GO:0014002) | 3.73756654 |
| 30 | regulation of collateral sprouting (GO:0048670) | 3.72142484 |
| 31 | leukocyte aggregation (GO:0070486) | 3.68074902 |
| 32 | auditory receptor cell differentiation (GO:0042491) | 3.66250949 |
| 33 | mast cell activation (GO:0045576) | 3.63452051 |
| 34 | striated muscle contraction (GO:0006941) | 3.62299127 |
| 35 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.61778309 |
| 36 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.58928771 |
| 37 | glycine transport (GO:0015816) | 3.56112751 |
| 38 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.55214880 |
| 39 | microglial cell activation (GO:0001774) | 3.55137659 |
| 40 | detection of other organism (GO:0098543) | 3.52839643 |
| 41 | interferon-gamma production (GO:0032609) | 3.49348388 |
| 42 | actin filament-based movement (GO:0030048) | 3.46561873 |
| 43 | amyloid precursor protein metabolic process (GO:0042982) | 3.45742292 |
| 44 | skeletal muscle adaptation (GO:0043501) | 3.43638339 |
| 45 | plasma membrane repair (GO:0001778) | 3.41671919 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.39946789 |
| 47 | amino acid import (GO:0043090) | 3.38465812 |
| 48 | response to inactivity (GO:0014854) | 3.36101132 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 3.35964559 |
| 50 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.34119815 |
| 51 | skeletal muscle fiber development (GO:0048741) | 3.32831243 |
| 52 | photoreceptor cell differentiation (GO:0046530) | 3.31020147 |
| 53 | eye photoreceptor cell differentiation (GO:0001754) | 3.31020147 |
| 54 | mast cell activation involved in immune response (GO:0002279) | 3.28989932 |
| 55 | mast cell degranulation (GO:0043303) | 3.28989932 |
| 56 | negative regulation of protein localization to cell surface (GO:2000009) | 3.27461783 |
| 57 | import into cell (GO:0098657) | 3.27435863 |
| 58 | T cell migration (GO:0072678) | 3.24845677 |
| 59 | negative regulation of neurotransmitter transport (GO:0051589) | 3.24503437 |
| 60 | response to peptidoglycan (GO:0032494) | 3.23385901 |
| 61 | detection of bacterium (GO:0016045) | 3.23123792 |
| 62 | macrophage activation (GO:0042116) | 3.22295552 |
| 63 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.22106685 |
| 64 | peripheral nervous system axon ensheathment (GO:0032292) | 3.18563996 |
| 65 | myelination in peripheral nervous system (GO:0022011) | 3.18563996 |
| 66 | myofibril assembly (GO:0030239) | 3.17553532 |
| 67 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.13361274 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13063145 |
| 69 | negative regulation of cell killing (GO:0031342) | 3.13063145 |
| 70 | response to host immune response (GO:0052572) | 3.12818566 |
| 71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12818566 |
| 72 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.09494126 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.05669605 |
| 74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05116948 |
| 75 | germinal center formation (GO:0002467) | 3.04933704 |
| 76 | positive regulation of gliogenesis (GO:0014015) | 3.04503846 |
| 77 | response to methylmercury (GO:0051597) | 3.03626422 |
| 78 | glycosylceramide metabolic process (GO:0006677) | 3.02792058 |
| 79 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.02134014 |
| 80 | membrane tubulation (GO:0097320) | 3.01567806 |
| 81 | response to host (GO:0075136) | 2.99498838 |
| 82 | response to host defenses (GO:0052200) | 2.99498838 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99498838 |
| 84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98473961 |
| 85 | potassium ion import (GO:0010107) | 2.97815154 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 2.95590436 |
| 87 | cellular response to interleukin-15 (GO:0071350) | 2.95427336 |
| 88 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.93385376 |
| 89 | detection of biotic stimulus (GO:0009595) | 2.92163775 |
| 90 | neuronal action potential propagation (GO:0019227) | 2.91450781 |
| 91 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.90243835 |
| 92 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90049559 |
| 93 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90049559 |
| 94 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.88250651 |
| 95 | glucan catabolic process (GO:0009251) | 2.86503966 |
| 96 | neutrophil activation (GO:0042119) | 2.86414298 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86077954 |
| 98 | cellular extravasation (GO:0045123) | 2.84777118 |
| 99 | cortical actin cytoskeleton organization (GO:0030866) | 2.84738174 |
| 100 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.83721941 |
| 101 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.82322922 |
| 102 | myotube cell development (GO:0014904) | 2.81685908 |
| 103 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.79055255 |
| 104 | cardiac muscle contraction (GO:0060048) | 2.78132386 |
| 105 | protein palmitoylation (GO:0018345) | 2.77845516 |
| 106 | negative T cell selection (GO:0043383) | 2.77695151 |
| 107 | cellular polysaccharide catabolic process (GO:0044247) | 2.77381914 |
| 108 | positive regulation of glial cell differentiation (GO:0045687) | 2.76456146 |
| 109 | Golgi to endosome transport (GO:0006895) | 2.75826617 |
| 110 | negative regulation of muscle contraction (GO:0045932) | 2.75073197 |
| 111 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73714947 |
| 112 | response to lipoprotein particle (GO:0055094) | 2.73346679 |
| 113 | striated muscle atrophy (GO:0014891) | 2.73321320 |
| 114 | asymmetric protein localization (GO:0008105) | 2.73088811 |
| 115 | glycogen catabolic process (GO:0005980) | 2.73084878 |
| 116 | ear development (GO:0043583) | 2.72836412 |
| 117 | striated muscle adaptation (GO:0014888) | 2.69393083 |
| 118 | neurotransmitter uptake (GO:0001504) | 2.69386503 |
| 119 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.69130940 |
| 120 | negative regulation of inclusion body assembly (GO:0090084) | 2.69045946 |
| 121 | myeloid cell activation involved in immune response (GO:0002275) | 2.68909566 |
| 122 | regulation of ARF protein signal transduction (GO:0032012) | 2.68899050 |
| 123 | positive regulation of myotube differentiation (GO:0010831) | 2.68706095 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.67059058 |
| 125 | negative thymic T cell selection (GO:0045060) | 2.66335799 |
| 126 | positive regulation of astrocyte differentiation (GO:0048711) | 2.66334605 |
| 127 | regulation of macrophage cytokine production (GO:0010935) | 2.65827028 |
| 128 | * substantia nigra development (GO:0021762) | 2.65694193 |
| 129 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.65274270 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65011433 |
| 131 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.64249760 |
| 132 | response to interleukin-15 (GO:0070672) | 2.63755910 |
| 133 | regulation of leukocyte degranulation (GO:0043300) | 2.62770916 |
| 134 | response to muscle activity (GO:0014850) | 2.62572580 |
| 135 | adult walking behavior (GO:0007628) | 2.62445412 |
| 136 | tolerance induction (GO:0002507) | 2.62223229 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61524490 |
| 138 | negative regulation of macroautophagy (GO:0016242) | 2.60312554 |
| 139 | positive regulation of mast cell activation (GO:0033005) | 2.59990291 |
| 140 | cortical cytoskeleton organization (GO:0030865) | 2.59378674 |
| 141 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59333513 |
| 142 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59172277 |
| 143 | respiratory burst (GO:0045730) | 2.59132704 |
| 144 | regulation of regulated secretory pathway (GO:1903305) | 2.57973148 |
| 145 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.57574001 |
| 146 | muscle contraction (GO:0006936) | 2.54440299 |
| 147 | negative regulation of myotube differentiation (GO:0010832) | 2.54378718 |
| 148 | negative regulation of axonogenesis (GO:0050771) | 2.54096594 |
| 149 | nerve growth factor signaling pathway (GO:0038180) | 2.53813791 |
| 150 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53464861 |
| 151 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.52983448 |
| 152 | positive regulation of mast cell degranulation (GO:0043306) | 2.52983448 |
| 153 | transmission of nerve impulse (GO:0019226) | 2.52882901 |
| 154 | amyloid precursor protein catabolic process (GO:0042987) | 2.52814889 |
| 155 | regulation of cell communication by electrical coupling (GO:0010649) | 2.52472808 |
| 156 | granulocyte activation (GO:0036230) | 2.51895861 |
| 157 | glial cell development (GO:0021782) | 2.51154908 |
| 158 | lysosome localization (GO:0032418) | 2.50704960 |
| 159 | negative regulation of interleukin-12 production (GO:0032695) | 2.49863734 |
| 160 | positive regulation of macrophage cytokine production (GO:0060907) | 2.49099692 |
| 161 | polysaccharide catabolic process (GO:0000272) | 2.48786967 |
| 162 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.48274227 |
| 163 | regulation of autophagic vacuole assembly (GO:2000785) | 2.42992331 |
| 164 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.39224520 |
| 165 | positive regulation of Rap GTPase activity (GO:0032854) | 2.38180624 |
| 166 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.35814664 |
| 167 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.35814664 |
| 168 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33860212 |
| 169 | presynaptic membrane organization (GO:0097090) | 2.33622361 |
| 170 | cyclic nucleotide catabolic process (GO:0009214) | 2.32595416 |
| 171 | regulation of extracellular matrix disassembly (GO:0010715) | 2.30364632 |
| 172 | neuronal ion channel clustering (GO:0045161) | 2.30042558 |
| 173 | glycerophospholipid catabolic process (GO:0046475) | 2.28809172 |
| 174 | protein localization to endosome (GO:0036010) | 2.28667357 |
| 175 | neuroblast proliferation (GO:0007405) | 2.28571659 |
| 176 | heterotypic cell-cell adhesion (GO:0034113) | 2.27485695 |
| 177 | regulation of lipoprotein metabolic process (GO:0050746) | 2.26761795 |
| 178 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.26034483 |
| 179 | negative regulation of JUN kinase activity (GO:0043508) | 2.24553939 |
| 180 | regulation of Rap GTPase activity (GO:0032317) | 2.24108674 |
| 181 | peripheral nervous system development (GO:0007422) | 2.24030330 |
| 182 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.23423670 |
| 183 | positive thymic T cell selection (GO:0045059) | 2.23388919 |
| 184 | adenosine receptor signaling pathway (GO:0001973) | 2.23252120 |
| 185 | apical protein localization (GO:0045176) | 2.23113001 |
| 186 | regulation of ARF GTPase activity (GO:0032312) | 2.22518666 |
| 187 | leukocyte degranulation (GO:0043299) | 2.21947943 |
| 188 | T cell receptor signaling pathway (GO:0050852) | 2.21433225 |
| 189 | glial cell differentiation (GO:0010001) | 2.21271247 |
| 190 | positive regulation of cell fate commitment (GO:0010455) | 2.20358576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00797629 |
| 2 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.46629531 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.91657640 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.83435874 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71524779 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.59356043 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50338258 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.28625862 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99857618 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97058583 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82550459 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82542460 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79938530 |
| 14 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.79470575 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77677620 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67952193 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65193158 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63486590 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.63416266 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63210219 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60672609 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58759322 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58541043 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56890722 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56667501 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56628558 |
| 27 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.55359927 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54357059 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.54192014 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.54192014 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52692595 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50637755 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49617861 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.48964338 |
| 35 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47002167 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45239025 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.40964372 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40941313 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39669233 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38292240 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36319553 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36049292 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35729318 |
| 44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33448107 |
| 45 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33448107 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31428787 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30519066 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30002903 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29865626 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28719699 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28540169 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27940945 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27824271 |
| 54 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.27309983 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27225506 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24590455 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22783095 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20199564 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18819267 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17943739 |
| 61 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.17613917 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17388806 |
| 63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15114636 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14438177 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14255743 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13709289 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13146048 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11379637 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10427139 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08716968 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08532175 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07440333 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07157864 |
| 74 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07013734 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.06676715 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06107241 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05973313 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05566851 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04084481 |
| 80 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03801709 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03376520 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02942890 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02671921 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02558825 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02303012 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02074611 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01433570 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99909715 |
| 89 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98804224 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97538981 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96394466 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96255386 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96100998 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95276325 |
| 95 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95248321 |
| 96 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.95099797 |
| 97 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95091465 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94839527 |
| 99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94395554 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94250570 |
| 101 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94216216 |
| 102 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93981664 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93573314 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93489146 |
| 105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93155408 |
| 106 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93143940 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92814815 |
| 108 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92782208 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92073160 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91694105 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91646014 |
| 112 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91613536 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91602933 |
| 114 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90961381 |
| 115 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90794093 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90384081 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90306213 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90237071 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89796621 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89481701 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89307667 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88615633 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88596322 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88319207 |
| 125 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88221257 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87855452 |
| 127 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.87175190 |
| 128 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87145184 |
| 129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85659313 |
| 130 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85393052 |
| 131 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85248279 |
| 132 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84164550 |
| 133 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83762085 |
| 134 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83619526 |
| 135 | MYB_26560356_Chip-Seq_TH1_Human | 0.83227497 |
| 136 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83188279 |
| 137 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83137336 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83008953 |
| 139 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82048469 |
| 140 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.81808316 |
| 141 | MAF_26560356_Chip-Seq_TH2_Human | 0.81466696 |
| 142 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81459867 |
| 143 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.80535561 |
| 144 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.79515863 |
| 145 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.79384738 |
| 146 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78110993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.74010361 |
| 2 | MP0003646_muscle_fatigue | 3.93488810 |
| 3 | MP0001485_abnormal_pinna_reflex | 3.61831122 |
| 4 | MP0003690_abnormal_glial_cell | 3.34307981 |
| 5 | MP0003724_increased_susceptibility_to | 3.20423458 |
| 6 | MP0005451_abnormal_body_composition | 2.96837330 |
| 7 | MP0004885_abnormal_endolymph | 2.96600451 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.93447557 |
| 9 | MP0004130_abnormal_muscle_cell | 2.79154400 |
| 10 | MP0005671_abnormal_response_to | 2.74504812 |
| 11 | MP0003303_peritoneal_inflammation | 2.50640675 |
| 12 | MP0004742_abnormal_vestibular_system | 2.48694925 |
| 13 | MP0001486_abnormal_startle_reflex | 2.47281964 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.43704139 |
| 15 | MP0006082_CNS_inflammation | 2.41126320 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.36381586 |
| 17 | MP0000383_abnormal_hair_follicle | 2.32491828 |
| 18 | MP0003436_decreased_susceptibility_to | 2.22626405 |
| 19 | MP0003880_abnormal_central_pattern | 2.16161289 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 2.15687951 |
| 21 | MP0003878_abnormal_ear_physiology | 2.15687951 |
| 22 | MP0003879_abnormal_hair_cell | 2.10773554 |
| 23 | MP0003329_amyloid_beta_deposits | 2.10505431 |
| 24 | MP0004087_abnormal_muscle_fiber | 2.08630337 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.03424391 |
| 26 | MP0005171_absent_coat_pigmentation | 2.02754194 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 2.01443631 |
| 28 | MP0010678_abnormal_skin_adnexa | 1.99746297 |
| 29 | MP0003634_abnormal_glial_cell | 1.98043754 |
| 30 | MP0004142_abnormal_muscle_tone | 1.95848663 |
| 31 | MP0002269_muscular_atrophy | 1.93591491 |
| 32 | MP0004270_analgesia | 1.92235887 |
| 33 | MP0002272_abnormal_nervous_system | 1.90211721 |
| 34 | MP0001963_abnormal_hearing_physiology | 1.90203723 |
| 35 | MP0008569_lethality_at_weaning | 1.85818442 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.79022044 |
| 37 | MP0004381_abnormal_hair_follicle | 1.78115919 |
| 38 | MP0000747_muscle_weakness | 1.76169941 |
| 39 | MP0002064_seizures | 1.73591896 |
| 40 | MP0000749_muscle_degeneration | 1.67611996 |
| 41 | MP0002229_neurodegeneration | 1.66739705 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.60556517 |
| 43 | MP0003828_pulmonary_edema | 1.60076262 |
| 44 | MP0008260_abnormal_autophagy | 1.58252002 |
| 45 | MP0004484_altered_response_of | 1.51761147 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.51534248 |
| 47 | MP0004134_abnormal_chest_morphology | 1.48898631 |
| 48 | MP0003136_yellow_coat_color | 1.48634292 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.45753334 |
| 50 | MP0001851_eye_inflammation | 1.44269255 |
| 51 | MP0005166_decreased_susceptibility_to | 1.44210971 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.43563785 |
| 53 | MP0005409_darkened_coat_color | 1.40010978 |
| 54 | MP0005423_abnormal_somatic_nervous | 1.39475058 |
| 55 | MP0009785_altered_susceptibility_to | 1.38790483 |
| 56 | MP0004233_abnormal_muscle_weight | 1.38261090 |
| 57 | MP0000026_abnormal_inner_ear | 1.38119175 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.36552569 |
| 59 | MP0003633_abnormal_nervous_system | 1.34637382 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.33520884 |
| 61 | MP0001905_abnormal_dopamine_level | 1.31574740 |
| 62 | MP0009745_abnormal_behavioral_response | 1.31222001 |
| 63 | MP0001790_abnormal_immune_system | 1.30160743 |
| 64 | MP0005387_immune_system_phenotype | 1.30160743 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.28767683 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.28705190 |
| 67 | MP0002420_abnormal_adaptive_immunity | 1.27462926 |
| 68 | MP0005330_cardiomyopathy | 1.26540489 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.25933639 |
| 70 | MP0003632_abnormal_nervous_system | 1.24487218 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.24412692 |
| 72 | MP0003631_nervous_system_phenotype | 1.23874332 |
| 73 | MP0001819_abnormal_immune_cell | 1.23699525 |
| 74 | MP0000778_abnormal_nervous_system | 1.21956983 |
| 75 | MP0002723_abnormal_immune_serum | 1.20710196 |
| 76 | MP0000604_amyloidosis | 1.20667763 |
| 77 | MP0001800_abnormal_humoral_immune | 1.19216314 |
| 78 | MP0002972_abnormal_cardiac_muscle | 1.18378655 |
| 79 | MP0002971_abnormal_brown_adipose | 1.18148463 |
| 80 | MP0003635_abnormal_synaptic_transmissio | 1.18064782 |
| 81 | MP0005623_abnormal_meninges_morphology | 1.15317908 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.14661445 |
| 83 | MP0002882_abnormal_neuron_morphology | 1.09317614 |
| 84 | MP0005310_abnormal_salivary_gland | 1.09305083 |
| 85 | MP0000955_abnormal_spinal_cord | 1.05476965 |
| 86 | MP0005464_abnormal_platelet_physiology | 1.05233171 |
| 87 | MP0002419_abnormal_innate_immunity | 1.03914114 |
| 88 | MP0003300_gastrointestinal_ulcer | 1.03901306 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.01925713 |
| 90 | MP0009278_abnormal_bone_marrow | 1.01686474 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 1.01671040 |
| 92 | MP0000733_abnormal_muscle_development | 0.99865803 |
| 93 | MP0003866_abnormal_defecation | 0.98840822 |
| 94 | MP0002452_abnormal_antigen_presenting | 0.97537240 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.97152230 |
| 96 | MP0001529_abnormal_vocalization | 0.96776115 |
| 97 | MP0008874_decreased_physiological_sensi | 0.95754758 |
| 98 | MP0000685_abnormal_immune_system | 0.93896142 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.93840744 |
| 100 | MP0010630_abnormal_cardiac_muscle | 0.92495357 |
| 101 | MP0002066_abnormal_motor_capabilities/c | 0.92305894 |
| 102 | MP0002933_joint_inflammation | 0.91965985 |
| 103 | MP0009046_muscle_twitch | 0.90912396 |
| 104 | MP0000372_irregular_coat_pigmentation | 0.89943297 |
| 105 | MP0005025_abnormal_response_to | 0.89576186 |
| 106 | MP0000716_abnormal_immune_system | 0.89396154 |
| 107 | MP0001502_abnormal_circadian_rhythm | 0.89183577 |
| 108 | MP0002106_abnormal_muscle_physiology | 0.89123728 |
| 109 | MP0003448_altered_tumor_morphology | 0.87524315 |
| 110 | MP0002067_abnormal_sensory_capabilities | 0.86681144 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.86208953 |
| 112 | MP0004883_abnormal_blood_vessel | 0.86179325 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.86101037 |
| 114 | MP0002398_abnormal_bone_marrow | 0.84826145 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.83447490 |
| 116 | MP0001970_abnormal_pain_threshold | 0.82897519 |
| 117 | MP0002108_abnormal_muscle_morphology | 0.81491357 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.81223437 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.78886297 |
| 120 | MP0005535_abnormal_body_temperature | 0.78835101 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.78450750 |
| 122 | MP0002148_abnormal_hypersensitivity_rea | 0.78076213 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.77983751 |
| 124 | MP0002405_respiratory_system_inflammati | 0.77252208 |
| 125 | MP0000759_abnormal_skeletal_muscle | 0.76965885 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.76934177 |
| 127 | MP0004510_myositis | 0.76774666 |
| 128 | MP0001873_stomach_inflammation | 0.76729145 |
| 129 | MP0000751_myopathy | 0.76345856 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.76038945 |
| 131 | MP0002063_abnormal_learning/memory/cond | 0.75964946 |
| 132 | MP0005266_abnormal_metabolism | 0.75380664 |
| 133 | MP0004043_abnormal_pH_regulation | 0.75126224 |
| 134 | MP0002734_abnormal_mechanical_nocicepti | 0.74708659 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.74510184 |
| 136 | MP0000703_abnormal_thymus_morphology | 0.74434991 |
| 137 | MP0003075_altered_response_to | 0.73891301 |
| 138 | MP0004036_abnormal_muscle_relaxation | 0.73637749 |
| 139 | MP0003045_fibrosis | 0.73610508 |
| 140 | MP0006036_abnormal_mitochondrial_physio | 0.73543270 |
| 141 | MP0002132_abnormal_respiratory_system | 0.73476888 |
| 142 | MP0003656_abnormal_erythrocyte_physiolo | 0.73460624 |
| 143 | MP0004147_increased_porphyrin_level | 0.71870292 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.71484080 |
| 145 | MP0004947_skin_inflammation | 0.71039515 |
| 146 | MP0004924_abnormal_behavior | 0.70872005 |
| 147 | MP0005386_behavior/neurological_phenoty | 0.70872005 |
| 148 | MP0004858_abnormal_nervous_system | 0.70329917 |
| 149 | MP0005369_muscle_phenotype | 0.68626743 |
| 150 | MP0005385_cardiovascular_system_phenoty | 0.65094609 |
| 151 | MP0001544_abnormal_cardiovascular_syste | 0.65094609 |
| 152 | MP0008469_abnormal_protein_level | 0.64802831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 5.88468045 |
| 2 | Peripheral hypomyelination (HP:0007182) | 4.73423838 |
| 3 | Neurofibrillary tangles (HP:0002185) | 4.41614728 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.26390872 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.26390872 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.09550743 |
| 7 | Slow saccadic eye movements (HP:0000514) | 3.93626629 |
| 8 | Abnormal auditory evoked potentials (HP:0006958) | 3.91173694 |
| 9 | Onion bulb formation (HP:0003383) | 3.89402360 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 3.70738840 |
| 11 | Cerebral hypomyelination (HP:0006808) | 3.69200408 |
| 12 | Increased connective tissue (HP:0009025) | 3.67198331 |
| 13 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.63552267 |
| 14 | Nemaline bodies (HP:0003798) | 3.54660864 |
| 15 | Exercise-induced myalgia (HP:0003738) | 3.54176531 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.52645420 |
| 17 | Ulnar deviation of the wrist (HP:0003049) | 3.47205748 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.42838261 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.40978877 |
| 20 | Subaortic stenosis (HP:0001682) | 3.40978877 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.38416703 |
| 22 | Ankle clonus (HP:0011448) | 3.26793196 |
| 23 | Increased variability in muscle fiber diameter (HP:0003557) | 3.21973574 |
| 24 | Distal lower limb muscle weakness (HP:0009053) | 3.16696646 |
| 25 | Myoglobinuria (HP:0002913) | 3.14405253 |
| 26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.11317557 |
| 27 | Frequent falls (HP:0002359) | 3.05999855 |
| 28 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.03786119 |
| 29 | Premature skin wrinkling (HP:0100678) | 2.98408322 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 2.96413550 |
| 31 | Spastic gait (HP:0002064) | 2.91252385 |
| 32 | Sensory axonal neuropathy (HP:0003390) | 2.86543214 |
| 33 | Parakeratosis (HP:0001036) | 2.85418177 |
| 34 | Abnormality of the corticospinal tract (HP:0002492) | 2.84644320 |
| 35 | Intention tremor (HP:0002080) | 2.82896511 |
| 36 | Dysmetria (HP:0001310) | 2.82785683 |
| 37 | Alacrima (HP:0000522) | 2.82300675 |
| 38 | Morphological abnormality of the inner ear (HP:0011390) | 2.81124851 |
| 39 | Exercise-induced muscle cramps (HP:0003710) | 2.80479100 |
| 40 | Abnormality of the calf musculature (HP:0001430) | 2.77908353 |
| 41 | Asymmetric septal hypertrophy (HP:0001670) | 2.77043925 |
| 42 | EMG: neuropathic changes (HP:0003445) | 2.75402922 |
| 43 | Fetal akinesia sequence (HP:0001989) | 2.74984569 |
| 44 | Bundle branch block (HP:0011710) | 2.68513069 |
| 45 | Orchitis (HP:0100796) | 2.67793534 |
| 46 | Myositis (HP:0100614) | 2.67281674 |
| 47 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.62508234 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.62311118 |
| 49 | Malignant hyperthermia (HP:0002047) | 2.60868941 |
| 50 | Epiphyseal dysplasia (HP:0002656) | 2.60762838 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.59793958 |
| 52 | Areflexia of lower limbs (HP:0002522) | 2.54031242 |
| 53 | T lymphocytopenia (HP:0005403) | 2.53357371 |
| 54 | Myopathic facies (HP:0002058) | 2.52917748 |
| 55 | Bulbar palsy (HP:0001283) | 2.52906596 |
| 56 | White forelock (HP:0002211) | 2.51602584 |
| 57 | Round ear (HP:0100830) | 2.50257618 |
| 58 | Hyperkalemia (HP:0002153) | 2.48900014 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.48456355 |
| 60 | Difficulty running (HP:0009046) | 2.46996505 |
| 61 | Akinesia (HP:0002304) | 2.44216230 |
| 62 | Clumsiness (HP:0002312) | 2.43736464 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.41357456 |
| 64 | Diplopia (HP:0000651) | 2.41357456 |
| 65 | Sudden death (HP:0001699) | 2.40850785 |
| 66 | Stridor (HP:0010307) | 2.39354926 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35089067 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35089067 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35089067 |
| 70 | Stomatitis (HP:0010280) | 2.33495866 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 2.33061700 |
| 72 | Patchy hypopigmentation of hair (HP:0011365) | 2.32867327 |
| 73 | Decreased lacrimation (HP:0000633) | 2.32757121 |
| 74 | Muscle fiber splitting (HP:0003555) | 2.32572811 |
| 75 | Absent phalangeal crease (HP:0006109) | 2.31931140 |
| 76 | Bell-shaped thorax (HP:0001591) | 2.27314466 |
| 77 | Gowers sign (HP:0003391) | 2.25754711 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.25748618 |
| 79 | Calf muscle hypertrophy (HP:0008981) | 2.25481805 |
| 80 | Hemiplegia (HP:0002301) | 2.25233445 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24712168 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.24229291 |
| 83 | Generalized muscle weakness (HP:0003324) | 2.22034573 |
| 84 | Rimmed vacuoles (HP:0003805) | 2.19823023 |
| 85 | Hyporeflexia of lower limbs (HP:0002600) | 2.18501679 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.18198648 |
| 87 | Optic neuritis (HP:0100653) | 2.16953234 |
| 88 | Retrobulbar optic neuritis (HP:0100654) | 2.16953234 |
| 89 | Calcaneovalgus deformity (HP:0001848) | 2.16950906 |
| 90 | Distal arthrogryposis (HP:0005684) | 2.16199168 |
| 91 | Mixed hearing impairment (HP:0000410) | 2.16019025 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15724830 |
| 93 | Chronic otitis media (HP:0000389) | 2.13966342 |
| 94 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.13668263 |
| 95 | Bowel incontinence (HP:0002607) | 2.13354333 |
| 96 | Myotonia (HP:0002486) | 2.11273658 |
| 97 | Scanning speech (HP:0002168) | 2.10863628 |
| 98 | Muscle stiffness (HP:0003552) | 2.10835591 |
| 99 | Urinary urgency (HP:0000012) | 2.10471415 |
| 100 | Hypoplasia of the iris (HP:0007676) | 2.09980761 |
| 101 | Anomalous pulmonary venous return (HP:0010772) | 2.08987420 |
| 102 | Abnormality of the ischium (HP:0003174) | 2.08766858 |
| 103 | Postural instability (HP:0002172) | 2.07701615 |
| 104 | Weak cry (HP:0001612) | 2.06347792 |
| 105 | Obstructive sleep apnea (HP:0002870) | 2.05911231 |
| 106 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.04652667 |
| 107 | Abnormality of macrophages (HP:0004311) | 2.04017807 |
| 108 | Chest pain (HP:0100749) | 2.03388669 |
| 109 | Congenital sensorineural hearing impairment (HP:0008527) | 2.03038440 |
| 110 | Abnormal large intestine physiology (HP:0012700) | 2.02252693 |
| 111 | Ventricular arrhythmia (HP:0004308) | 1.97586779 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 1.97241657 |
| 113 | Lower limb amyotrophy (HP:0007210) | 1.97046772 |
| 114 | Rapidly progressive (HP:0003678) | 1.96294382 |
| 115 | Foot dorsiflexor weakness (HP:0009027) | 1.95077869 |
| 116 | Increased CSF protein (HP:0002922) | 1.93920228 |
| 117 | Nonprogressive disorder (HP:0003680) | 1.90244889 |
| 118 | Hypoproteinemia (HP:0003075) | 1.89573309 |
| 119 | Abnormal finger flexion creases (HP:0006143) | 1.89460993 |
| 120 | CNS hypomyelination (HP:0003429) | 1.89025886 |
| 121 | EMG: myopathic abnormalities (HP:0003458) | 1.88629249 |
| 122 | Axonal loss (HP:0003447) | 1.86233959 |
| 123 | Mediastinal lymphadenopathy (HP:0100721) | 1.85658112 |
| 124 | Abnormality of saccadic eye movements (HP:0000570) | 1.85306025 |
| 125 | Absent septum pellucidum (HP:0001331) | 1.84968894 |
| 126 | Spontaneous hematomas (HP:0007420) | 1.83580361 |
| 127 | Difficulty climbing stairs (HP:0003551) | 1.82651035 |
| 128 | Scapular winging (HP:0003691) | 1.82079368 |
| 129 | Abnormality of the neuromuscular junction (HP:0003398) | 1.81008245 |
| 130 | Fatigable weakness (HP:0003473) | 1.81008245 |
| 131 | Deformed tarsal bones (HP:0008119) | 1.80978721 |
| 132 | Poor speech (HP:0002465) | 1.80917320 |
| 133 | Slender build (HP:0001533) | 1.80055066 |
| 134 | Panhypogammaglobulinemia (HP:0003139) | 1.80021904 |
| 135 | Gingivitis (HP:0000230) | 1.79568484 |
| 136 | Recurrent fungal infections (HP:0002841) | 1.77391052 |
| 137 | Heart block (HP:0012722) | 1.77320298 |
| 138 | Abnormality of the foot musculature (HP:0001436) | 1.77248598 |
| 139 | Neck muscle weakness (HP:0000467) | 1.77140017 |
| 140 | Urinary incontinence (HP:0000020) | 1.77036902 |
| 141 | Paraparesis (HP:0002385) | 1.75492965 |
| 142 | Amyloidosis (HP:0011034) | 1.75492751 |
| 143 | Increased IgE level (HP:0003212) | 1.75045606 |
| 144 | Waddling gait (HP:0002515) | 1.75009006 |
| 145 | Metabolic alkalosis (HP:0200114) | 1.74171346 |
| 146 | Spastic paraparesis (HP:0002313) | 1.73409859 |
| 147 | Neuronal loss in central nervous system (HP:0002529) | 1.73025698 |
| 148 | Obstructive lung disease (HP:0006536) | 1.72697206 |
| 149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72697206 |
| 150 | Ventricular tachycardia (HP:0004756) | 1.72600387 |
| 151 | Anteriorly placed anus (HP:0001545) | 1.71810596 |
| 152 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71296696 |
| 153 | Abnormality of the endocardium (HP:0004306) | 1.70748199 |
| 154 | Increased circulating renin level (HP:0000848) | 1.70079539 |
| 155 | Loss of speech (HP:0002371) | 1.69811636 |
| 156 | Episodic fever (HP:0001954) | 1.69759379 |
| 157 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69678257 |
| 158 | Recurrent abscess formation (HP:0002722) | 1.69186892 |
| 159 | Recurrent skin infections (HP:0001581) | 1.69133109 |
| 160 | Facial diplegia (HP:0001349) | 1.67976271 |
| 161 | Meningitis (HP:0001287) | 1.67843255 |
| 162 | Rigidity (HP:0002063) | 1.67749641 |
| 163 | Keratoconjunctivitis sicca (HP:0001097) | 1.67644907 |
| 164 | Hypochromic microcytic anemia (HP:0004840) | 1.65247889 |
| 165 | Easy fatigability (HP:0003388) | 1.63955021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.36242395 |
| 2 | EPHB1 | 4.26036456 |
| 3 | RIPK4 | 3.46403328 |
| 4 | TXK | 3.35579628 |
| 5 | OXSR1 | 2.81553306 |
| 6 | MAP2K3 | 2.70857469 |
| 7 | CLK1 | 2.47606741 |
| 8 | MAPKAPK5 | 2.27026848 |
| 9 | PKN1 | 2.22771255 |
| 10 | NEK6 | 2.13827711 |
| 11 | WNK1 | 2.08879612 |
| 12 | MAP4K1 | 2.02315728 |
| 13 | PHKG1 | 1.86882283 |
| 14 | PHKG2 | 1.86882283 |
| 15 | UHMK1 | 1.80029231 |
| 16 | TNIK | 1.77848656 |
| 17 | ROCK2 | 1.72841204 |
| 18 | TYK2 | 1.72316405 |
| 19 | ITK | 1.70901197 |
| 20 | CDK19 | 1.68901350 |
| 21 | ERN1 | 1.66009077 |
| 22 | TRPM7 | 1.65153817 |
| 23 | KSR2 | 1.63543810 |
| 24 | TESK2 | 1.62651512 |
| 25 | FGFR2 | 1.61665911 |
| 26 | PRPF4B | 1.60023764 |
| 27 | TNK2 | 1.59276295 |
| 28 | TRIB3 | 1.55896469 |
| 29 | OBSCN | 1.50356838 |
| 30 | LIMK1 | 1.46973017 |
| 31 | CSNK1A1L | 1.45960989 |
| 32 | RIPK1 | 1.42493314 |
| 33 | FES | 1.41646419 |
| 34 | SGK223 | 1.36815715 |
| 35 | SGK494 | 1.36815715 |
| 36 | DAPK2 | 1.29618683 |
| 37 | PINK1 | 1.29343422 |
| 38 | MAP3K1 | 1.28513406 |
| 39 | MAP2K4 | 1.26493301 |
| 40 | DDR2 | 1.25779945 |
| 41 | CSNK1G3 | 1.24403246 |
| 42 | MAP3K11 | 1.23587467 |
| 43 | TAOK1 | 1.23075352 |
| 44 | MAP3K3 | 1.21006030 |
| 45 | SGK3 | 1.18041473 |
| 46 | PRKCH | 1.17934852 |
| 47 | JAK2 | 1.17933371 |
| 48 | PRKCQ | 1.13936094 |
| 49 | JAK1 | 1.13289048 |
| 50 | GRK7 | 1.12656071 |
| 51 | FGR | 1.09646240 |
| 52 | CAMK2B | 1.09369512 |
| 53 | BLK | 1.08718170 |
| 54 | MAP3K7 | 1.06893330 |
| 55 | DMPK | 1.05091230 |
| 56 | WNK4 | 1.05037791 |
| 57 | ICK | 1.03190237 |
| 58 | SGK2 | 1.02703037 |
| 59 | MAP3K13 | 1.00706287 |
| 60 | TYRO3 | 0.98415945 |
| 61 | BMX | 0.98074331 |
| 62 | MAPK15 | 0.96654252 |
| 63 | NTRK3 | 0.96069618 |
| 64 | EEF2K | 0.95051185 |
| 65 | CSNK1G1 | 0.91824232 |
| 66 | GRK6 | 0.91234487 |
| 67 | STK10 | 0.90916832 |
| 68 | MARK2 | 0.89548523 |
| 69 | MAP2K6 | 0.88152888 |
| 70 | LCK | 0.87632037 |
| 71 | CSNK1G2 | 0.87238718 |
| 72 | MAP3K2 | 0.87114196 |
| 73 | NTRK2 | 0.85611910 |
| 74 | ADRBK2 | 0.83479545 |
| 75 | JAK3 | 0.83362381 |
| 76 | MET | 0.83046094 |
| 77 | BCR | 0.82449039 |
| 78 | NME1 | 0.81334467 |
| 79 | IRAK4 | 0.78929791 |
| 80 | KIT | 0.78724198 |
| 81 | TBK1 | 0.78262266 |
| 82 | CAMK1G | 0.75803991 |
| 83 | NTRK1 | 0.75454014 |
| 84 | PIK3CA | 0.73727930 |
| 85 | PDK1 | 0.71908366 |
| 86 | SIK1 | 0.71896474 |
| 87 | CSK | 0.71822032 |
| 88 | HCK | 0.71813567 |
| 89 | MST4 | 0.71386551 |
| 90 | PTK6 | 0.70695312 |
| 91 | PRKAA2 | 0.70032457 |
| 92 | PDPK1 | 0.69730427 |
| 93 | CAMK2D | 0.67696936 |
| 94 | PRKD1 | 0.67688543 |
| 95 | CDK5 | 0.66617818 |
| 96 | CAMK4 | 0.66367769 |
| 97 | IRAK2 | 0.66152602 |
| 98 | CAMK2G | 0.65674242 |
| 99 | BTK | 0.65412475 |
| 100 | MOS | 0.64512163 |
| 101 | STK38 | 0.63689139 |
| 102 | ALK | 0.62897942 |
| 103 | FYN | 0.62041675 |
| 104 | CAMK1 | 0.61825546 |
| 105 | MARK1 | 0.61631124 |
| 106 | RET | 0.61629742 |
| 107 | YES1 | 0.61130968 |
| 108 | PAK6 | 0.61107590 |
| 109 | HIPK2 | 0.60753386 |
| 110 | PIK3CG | 0.60293095 |
| 111 | ZAP70 | 0.60181871 |
| 112 | DYRK1B | 0.58154855 |
| 113 | TTN | 0.57195368 |
| 114 | CSF1R | 0.56676881 |
| 115 | CAMKK1 | 0.56622922 |
| 116 | MAP3K6 | 0.55956296 |
| 117 | PDGFRB | 0.55651021 |
| 118 | CDC42BPA | 0.53860258 |
| 119 | MAPK12 | 0.52819134 |
| 120 | TGFBR2 | 0.52310457 |
| 121 | PTK2B | 0.52175283 |
| 122 | SGK1 | 0.49950412 |
| 123 | EPHA3 | 0.48748547 |
| 124 | PRKG2 | 0.47124360 |
| 125 | MAPK10 | 0.45411286 |
| 126 | PNCK | 0.45356567 |
| 127 | FGFR3 | 0.44713156 |
| 128 | SYK | 0.44058076 |
| 129 | IRAK1 | 0.44047887 |
| 130 | MAP3K14 | 0.43965283 |
| 131 | MAP2K1 | 0.43767355 |
| 132 | PRKD2 | 0.43400734 |
| 133 | KSR1 | 0.41690143 |
| 134 | MAPK4 | 0.41446076 |
| 135 | CSNK1D | 0.41347685 |
| 136 | TAOK2 | 0.40515811 |
| 137 | CDK14 | 0.40318060 |
| 138 | IRAK3 | 0.36884889 |
| 139 | PBK | 0.36876155 |
| 140 | MUSK | 0.36826539 |
| 141 | MAPK13 | 0.35918015 |
| 142 | CDK15 | 0.34558684 |
| 143 | IKBKE | 0.34432838 |
| 144 | LYN | 0.34299783 |
| 145 | MAPK7 | 0.33502807 |
| 146 | PRKG1 | 0.33445478 |
| 147 | LRRK2 | 0.32849000 |
| 148 | STK11 | 0.31935452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.95241985 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29523457 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.25593698 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.22764305 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.19032341 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.97028215 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.95518114 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.86921920 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85666735 |
| 10 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.82654522 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79425112 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74895649 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70619492 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.68017334 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67370472 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65358911 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.60643776 |
| 18 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.56798352 |
| 19 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46244370 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36900941 |
| 21 | Axon guidance_Homo sapiens_hsa04360 | 1.34127049 |
| 22 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.32436394 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29341690 |
| 24 | Endocytosis_Homo sapiens_hsa04144 | 1.28478534 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.27777488 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27058114 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.23842190 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.21359762 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19226056 |
| 30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19208730 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14577406 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13361006 |
| 33 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.12583141 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.12506458 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08356480 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08126937 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.08031105 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07030494 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06275328 |
| 40 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05350294 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.04618173 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 1.04287292 |
| 43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03489468 |
| 44 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.03471251 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03404669 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02739050 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01768347 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01630132 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01016414 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99882586 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99037074 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98952471 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97458890 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97448272 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96259699 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94380404 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94023203 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93043448 |
| 59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92708398 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91502903 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.91448622 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89985092 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89311600 |
| 64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.88984734 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88128307 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86266805 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86205264 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86124713 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86121471 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85565320 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.83844963 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83370368 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83001114 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.82750695 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82295826 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80704662 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80669992 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80406871 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80291029 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79845692 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.78502013 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.78244230 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77555491 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.77400112 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77388064 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75357752 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74957555 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74942096 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74753785 |
| 90 | Malaria_Homo sapiens_hsa05144 | 0.74545669 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74426586 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73865426 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73663496 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.73429218 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71929702 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71810308 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71117523 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70572051 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.70456329 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.70356204 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70056310 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69468349 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69358202 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69279417 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69102748 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.68576433 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67732239 |
| 108 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.67548904 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66613397 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.66468917 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66284813 |
| 112 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65664220 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64831549 |
| 114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64710991 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63284788 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62597722 |
| 117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62222761 |
| 118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62188472 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.61749238 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61320951 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61299606 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61277054 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60726590 |
| 124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60558306 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60219681 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58999760 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58347976 |
| 128 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57542231 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57166146 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56432790 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54896689 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54587893 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.54205332 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53953537 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53807886 |
| 136 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53664118 |
| 137 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53631717 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53300557 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53134596 |
| 140 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52849685 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52657163 |
| 142 | Shigellosis_Homo sapiens_hsa05131 | 0.52456284 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.51813521 |

